Thus, VEGF-A165b levels may be increased in early stage diabetic nephropathy to inhibit hyperglycemia-induced glomerular hyperfiltration, which is known to be mediated by upregulation of VEGF-A in podocytes. The gene discussed is VEGFA; the disease is diabetic kidney disease.